According to WHO, 73 countries have warned that they are at risk of running out on antiretroviral HIV drugs due to COVID-19, and 24 of which have reported having either a critically low stock or experiencing a disruption in supply.
This is based on the new WHO survey conducted ahead of the International AIDS Society’s biannual conference. “The findings of this survey are deeply concerning,” WHO Director-General Dr. Tedros Adhanom Ghebreyesus said in a statement. “Countries and their development partners must do all they can to ensure that people who need HIV treatment continue to access it. We cannot let the COVID-19 pandemic undo the hard-won gains in the global response to this disease,” he added.